Optimal frequency of imiquimod (Aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: A meta-analysis

Sexually Transmitted Diseases

Volumn 35, Issue 4, 2008, Pages 346-351

  Gotovtseva, Elena P ^a,b   Kapadia, Asha S ^a   Smolensky, Michael H ^a   Lairson, David R ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b University of Texas Health Science Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ARTICLE; BEDTIME DOSAGE; CIRCUMCISION; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; IMMUNOCOMPETENCE; INCIDENCE; LOCAL SKIN REACTION; META ANALYSIS; MONOTHERAPY; OUTCOME ASSESSMENT; PREPUCE; SYSTEMATIC REVIEW; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADULT; AMINOQUINOLINES; CIRCUMCISION, MALE; CONDYLOMATA ACUMINATA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOCOMPETENCE; INTERFERON INDUCERS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 41149127321     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31815ea8d1     Document Type: Article

References (30)

1. Brown DR, Schroeder JM, Bryan JT, et al. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999; 37:3316-3322.
2. Stanley M. Immune responses to human papillomavirus. Vaccine 2006; 24 (Suppl 1):S16-S22.
3. De Panfilis G, Melzani G, Mori G, et al. Relapses after treatment of external genital warts are more frequent in HIV-positive patients than in HIV-negative controls. Sex Transm Dis 2002; 29:121-125.
4. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102(5A):3-8.
5. Insinga RP, Dasbach EJ, Myers ER. The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis 2003; 36:1397-1403.
6. Maw RD, Reitano M, Roy M. An international survey of patients with genital warts: Perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998; 9:571-578.
7. Insinga RP, Dasbach EJ, Elbasha EH. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: Analytic framework and review of the literature. Pharmacoeconomics 2005; 23:1107-1122.
8. Scheinfeld NS. Warts: A guide to their removal. Consultant 2006; 46:333-340.
9. Maw R. Critical appraisal of commonly used treatment for genital warts. Int J STD AIDS 2004; 15:357-364.
10. Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol 2000; 43(1 Pt 2):S6-S11.
11. Schon MP, Schon M. Immune modulation and apoptosis induction: Two sides of the antitumoral activity of imiquimod. Apoptosis 2004; 9:291-298.
12. Arany I, Tyring SK, Stanley MA, et al. Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%. Antiviral Res 1999; 43:55-63.
13. Edwards L, Ferenczy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV study group. Human Papillomavirus Arch Dermatol 1998; 134:25-30.
14. Gollnick H, Barasso R, Jappe U, et al. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day. Int J STD AIDS 2001; 12:22-28.
15. Garland SM, Sellors JW, Wikstrom A, et al. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts-results of an open-label, multicentre phase IIIB trial. Int J STD AIDS 2001; 12:722-729.
16. Moore RA, Edwards JE, Hopwood J, et al. Imiquimod for the treatment of genital warts: A quantitative systematic review. BMC Infect Dis 2001; 1:3.
17. CDC. Sex Transm Dis Treatment Guidelines, 2006. MMWR 2006; 55:No. RR-11.
18. Fife KH, Ferenczy A, Douglas JM Jr, et al. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day. Sex Transm Dis 2001; 28:226-231.
19. Trofatter KF Jr, Ferenczy A, Fife KH. Increased frequency of dosing of imiquimod 5% cream in the treatment of external genital warts in women. Int J Gynaecol Obstet 2002; 76:191-193.
20. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17:1-12.
21. McCulloch M, Broffman M, Gao J, et al. Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: A meta-analysis of randomized, controlled trials. Am J Public Health 2002; 92:1619-1628.
22. Laird NM, Mosteller F. Some statistical methods for combining experimental results. Int J Technol Assess Health Care 1990; 6:5-30.
23. Beutner KR, Tyring SK, Trofatter KF Jr, et al. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother 1998; 42:789-794.
24. Garland SM, Waddell R, Mindel A, et al. An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women. Int J STD AIDS 2006; 17:448-452.
25. Vilata JJ, Badia X, ESCCRIM g. Effectiveness, satisfaction and compliance with imiquimod in the treatment of external anogenital warts. Int J STD AIDS 2003; 14:11-17.
26. Brady S, Wilson JD. Closing the feedback loop: An audit of the use of imiquimod for the treatment of genital warts. J Eur Acad Dermatol Venereol 2004; 18:314-317.
27. Clegg A, Scott DA, Hewitson P, et al. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: A systematic review. Thorax 2002; 57:20-28.
28. Conn VS, Rantz MJ. Research methods: Managing primary study quality in meta-analyses. Res Nurs Health 2003;26:322-333.
29. Sauder DN, Skinner RB, Fox TL, et al. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations. Sex Transm Dis 2003; 30:124-128.
30. Petitti DB. Meta-Analysis, Decision-Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine. New York, NY: Oxford University Press, 2000.